The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $232. Insiders have been net sellers over the past quarter.
Progressive Corporation
PGR · a US exchange · USD · Market cap $124.9B · 70,053 employees
The Progressive Corporation operates as an insurance company in the United States.
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Progressive Corporation holds its Markup at $214.90. Consolidating, no directional conviction, held for 4 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 4 days |
| Price at the screen | $214.90 |
| Valuation | 10.79 trailing · 13.19 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.26 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 4% discount to our $223.31 fair value, moderate competitive moat, 7.30% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 3.9% margin of safety to the base estimate.
Third-party analyst targets: 21 covering, consensus Hold. The average target sits +8% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsProgressive Corporation - Missed Mark on Ethics
Imagine buying insurance from a company that could be construed as aiding and abetting unethical activities. That's the bind when it comes to Progressive Corporation. The company underwrites insurance for personal vehicles and properties, but it fails our ethical screen, due to specific business activities that don't align with our values. Why it stands out. Despite solid financials – a forward P/E of 13.5x, 7% revenue growth, and a healthy 13% profit margin – the ethical failure means we must give this a wide berth.
The market, however, has a different opinion, with analysts giving a consensus hold rating and a median target price of $228. Yet, when a company's business practices contradict our ethical standards, the numbers, no matter how appealing, cannot justify an investment. Risk sits in the company's moderate moat and the fact that it operates in a competitive insurance market, where reputation is paramount.
Analysis, not advice.
| Forward P/E | 13.2xpriced for continued growth |
| Trailing P/E | 10.8xreasonably valued |
| EPS, trailing | 19.92 |
| EPS, forward | 16.29 |
| Revenue growth | +7.3%slow but positive growth |
| Profit margin | 12.8%thin but positive margins |
| Return on equity | 34.9%an exceptional return on shareholder capital |
| FCF yield | 12.10% |
| Dividend yield | 716.00% |
| Debt to equity | 0.24minimal debt: a conservative balance sheet |
| Current ratio | 0.29below 1: short-term bills exceed liquid assets |
| Beta | 0.26barely tracks the market's swings |
| Short interest, float | 0.01% |
| 52-week range | 189.20 - 249.71 |
| Moat | MODERATE |
| Market cap | $124.9B |
| Employees | 70,053 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradePGR trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $230. Insiders have been net sellers over the past quarter.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it hold, with a mean price target of $230. Insiders have been net sellers over the past quarter.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 Insurers to Watch as Competition in Personal Auto Intensifies Zacks · 11d ago
- Progressive (PGR) Outperforms Broader Market: What You Need to Know Zacks · 16d ago
- The "Untouchable" List: Stocks That Short Sellers Won't Dare Bet Against GuruFocus.com · 16d ago
- CB Stock Trades at 1.62x Book Value: Is the Valuation Worth It? Zacks · 16d ago
- Insurers Are Buying Back More Stock as Pricing Softens Motley Fool · 17d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-16 | Johnson Devin C | Dir | Sale | 980 | $199,038 |
| 2026-03-20 | Joyce Carl G | Chief Accounting Officer | Sale | 270 | $55,754 |
| 2026-03-05 | Joyce Carl G | Chief Accounting Officer | Sale | 141 | $29,892 |
| 2026-03-05 | Bailo Karen | Commercial Lines Pres | Sale | 3,517 | $745,604 |
| 2026-02-24 | Pumarejo Maribel | Chief Marketing Oficer | Sale | 739 | $150,138 |
| 2026-02-23 | Bauer Jonathan S. | Chief Investment Officer | Sale | 2,266 | $460,111 |
| 2026-01-21 | Quigg Andrew J | Chief Strategy Officer | Sale | 1,649 | $336,973 |
| 2026-01-21 | Bauer Jonathan S. | Chief Investment Officer | Sale | 3,105 | $634,507 |
| 2025-12-19 | Broz Steven | CIO | Sale | 1,344 | $302,131 |
| 2025-11-28 | Sauerland John P | VP, CFO | Sale | 5,000 | $1,142,400 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-07-17 | Gil Cisneros | Democrat | sell | 1K–15K |
| 2026-07-17 | Gil Cisneros | Democrat | sell | 1K–15K |
| 2026-07-17 | Gil Cisneros | Democrat | sell | 1K–15K |
| 2026-06-16 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-05-15 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $196.91 | +3.6% | · | $1,036 | +3.6% |
| 2 months | $194.13 | +5.1% | · | $1,051 | +5.1% |
| 3 months | $205.07 | -0.6% | $0.10 | $995 | -0.5% |
| 6 months | $216.57 | -5.8% | $13.70 | $1,005 | +0.5% |
| 1 year | $249.31 | -18.2% | $13.90 | $874 | -12.6% |
| 2 years | $193.50 | +5.4% | $18.80 | $1,151 | +15.1% |
| 3 years | $119.62 | +70.5% | $19.95 | $1,872 | +87.2% |
| 5 years | $83.69 | +143.7% | $22.25 | $2,703 | +170.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PGR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.